% Expired Patents = 20.0

EPO Patents = 2

Forward Citations = 14

Loading Chart...

9 inventors (with patents filed for the assignee):

Emanuele Attolino (3 out of 20 patents)

Niccolo Santillo (1 out of 1 patent)

Chiara Conti (1 out of 1 patent)

4. Salvatore Agostino Giammillari (1 out of 1 patent)

5. Giuseppe Maccari (1 out of 2 patents)

6. Gabriele Razzetti (1 out of 35 patents)

7. Anilkumar Surendrakumar Gandhi (1 out of 16 patents)

8. Maharukh Tehmasp Rustomjee (1 out of 13 patents)

9. Niccolò Santillo (0 patent)

5 patents: Sort by Forward Citations

1. 11180454 - Synthesis of an azasugar and intermediates thereof (2021-11-23),

2. 10888527 - Stable solid pharmaceutical formulations containing 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cylcohexanedione (2021-01-12),

3. 10093610 - Crystalline inhibitor of 4-hydroxyphenylpyruvate dioxygenase (2018-10-09),

4. 9783485 - Crystalline inhibitor of 4-hydroxyphenylpyruvate dioxygenase, and a process of synthesis and crystallization thereof (2017-10-10),

5. 9492451 - Stable compositions of tetrahydrobiopterin (2016-11-15),

Company Overview

Dipharma Sa is a global pharmaceutical company specializing in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs). With a strong focus on research and innovation, Dipharma Sa delivers high-quality, cost-effective solutions to the healthcare industry. Their state-of-the-art facilities and experienced team ensure the highest standards of safety and efficacy in their products.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

5 Patents

#5 in Chiasso

#1,822 in Switzerland

Chiasso, Switzerland

Dipharma Sa

Forward Citations = 14

9 inventors:

Emanuele Attolino (3 out of 20 patents)

Niccolo Santillo (1 out of 1 patent)

Chiara Conti (1 out of 1 patent)

4. Salvatore Agostino Giammillari (1 out of 1 patent)

5. Giuseppe Maccari (1 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Dipharma Sa. Retrieved from https://idiyas.com/company/dipharma-sa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]